Helicobacter pylori seropositivity in fibromyalgia syndrome

Nuray Akkaya1, Semih Akkaya, Yusuf Polat

  • 1Department of Physical Medicine and Rehabilitation, Pamukkale University Medical School, Denizli, Turkey. nrakkaya@gmail.com

Clinical Rheumatology
|December 2, 2010
PubMed

Insights

Previous Helicobacter pylori (HP) infection may play a role in fibromyalgia syndrome (FM) development. Researchers found higher HP IgG antibody seropositivity in FM patients compared to controls, suggesting a potential link.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Rheumatology

Background:

  • Fibromyalgia syndrome (FM) lacks a definitive cause, but infections are being investigated.
  • Helicobacter pylori (HP) infection can manifest beyond the gastrointestinal tract.
  • Inflammation is implicated in FM pathophysiology and sympathetic nervous system activity.

Purpose of the Study:

  • To compare Helicobacter pylori (HP) seropositivity between fibromyalgia patients and healthy controls.
  • To explore the potential role of HP infection in the etiopathogenesis of fibromyalgia syndrome.

Main Methods:

  • Enzyme-linked immunosorbent assay (ELISA) was used to measure serum HP IgA and IgG antibodies.
  • Sixty-five female fibromyalgia patients and 41 age-matched female healthy controls were enrolled.
  • Fibromyalgia Impact Questionnaire (FIQ) was used for symptom assessment.

Main Results:

  • Seropositivity for HP IgG antibodies was significantly higher in fibromyalgia patients compared to controls.
  • No significant clinical differences were observed between HP IgG-positive and HP IgG-negative fibromyalgia patients.
  • The study noted the high general seroprevalence of HP, complicating interpretation.

Conclusions:

  • Former HP infection may be a contributing factor or trigger in fibromyalgia syndrome development.
  • Further research is needed to elucidate the precise role of HP in FM.
  • Understanding FM's pathophysiology is key to developing effective treatments.

Related Concept Videos

Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.